BILE DUCT CANCER RECURRENT

This adverse event was reported 28 times

BILE DUCT CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DURVALUMAB 7 0.0003
1 ALOGLIPTIN 1 0.0003
2 OLOPATADINE HYDROCHLORIDE OPHTHALMIC 1 0.0002
3 OLOPATADINE HYDROCHLORIDE 1 0.0002
4 VONOPRAZAN FUMARATE 1 0.0001
5 VANCOMYCIN HYDROCHLORIDE 1 0.0001
6 LUBIPROSTONE 1 0.0001
7 GEMCITABINE HYDROCHLORIDE 5 0.0001
8 ITRACONAZOLE 1 0.0001
9 PEGFILGRASTIM 1 0.0001
See all drugs enriched for association with BILE DUCT CANCER RECURRENT